New partnership aims to advance predictive tests for multiple myeloma in Ireland
By combining genomic testing and next generation sequencing technology, a new partnership led by RCSI researchers aims to advance predictive tests for multiple myeloma, the second most common blood cancer in Ireland.
.png)
No hay comentarios:
Publicar un comentario